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Osteoporosis in adult pafients with cystic fibrosis is correlated to 
high follicle sfimulating hormone levels 
G. Perpati 1, A. Benidis 1, V. Dionysopoulou 1, E. Stefanat ou 1, E. I l iadi 1, E. Kalat zi 1, 
Ch. B atsakis 2, A. Papamichalopoulos 1, J. Christakopoulou 2, E. Pouliou 1 
~Cystic fibrosis Outpatient Clinic, Athens Chest Hospital, 2Department of Nuclear 
Medicine, Athens Chest Hospital 
INTRODUfiq' ION: The prevalence of osteoporosis in adult patients with cystic 
fibrosis (CF) is higher than that reported ha children. Hypogonadism may 
exacerbate low bone mineral density (BM])). 
AIM: The aim of this study was to explore the relationship between levels of 
gonadotrofic hormones mad mean BM])  at spine and femur in adult CF patients. 
PATIENTS ME]TIODS: 26 patients with CF (14 male/12 female aged 24 + 6) were 
investigated. They were on stable state with Schwachman score (SS) 69 + 10 and 
forced expiratory volume ha first second (FEVI) 60% + 35. Dual  energy x ray 
absortiometry (DEXA) was used to measure BM])  at lumbar spine mad femur 
(neck). Immunoradiometric assay was used for estimating serum levels of foll icle 
stimulating hormone ( FSH ) and luteinizing hormone (LH). 
RESULTS: 8 patients had osteopenia t spine and 4 at femur. 4 patients had 
osteopor osis at spine mad 3 at femur. 13 from 26 patients had abnormal Dexa (at one 
or both sites). Decreased BM])  in this group is showed to have negative correlation 
to FSH levels (r 0.55, p<0.019), but no correlation is showed to LH levels (r 
0.29, p<0.22). 
CONCLUSION: Osteoporosis in adult patients with cystic fibrosis is correlated to 
high FSH levels. 
319 
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Osleoporosis has been reported as a complication of &yslic Fibrosis (CF). R isk 
factors include inadequate dietary intake, inactivity, steroid use and low 
concentrations of sex hormones. Aim: To determine whether osteoporosis is 
prevalent in clinically stable CF adult patients. Methods: Bone mineral density at 
the lumbar spine (LS) was assessed by dual energy X ray absorptiometry (DEXA) 
in 15 CF adult patients (8 males). None had been acutely il l  for at least four weeks 
and had not taken oral or intravenous steroids. Nodular bil iary cirdaosis was present 
in 6/15 patients. Dietary intake of Ca, P and vitamin D were calculated on 5<lay 
intake diary. Serum levels of Ca, P, Parathormone and sex hormones were 
measured. Results: BMI)  T scores ranged between 0.26 mad 1.74 at LS. T score 
l to  2.5 indicative of osteopenia had 4/15 CF patients. Par athor mane was slight ly 
increased ha 3/4 patients. No patient had osteopor osis (T score~2.5).  Although Ca, 
P and vitamin D intake was lower than 150% of the daily requirements, blood 
values were normal. Sex hormones were also within normal range. Conclusion: 
Osleoporosis was not detected among our CF population, who had good clinical 
status, did not receive steroids mad had sufficient physical activity and sunlight 
exposure. Our study does not support he concept hat the majority of CF patients 
have osteopenia or osteoporosis, which may differ from country to country. 
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Bone mineralisation and turnover in 8 to 12 year-old children with 
cystic fibrosis 
C. Benden 1, A. Jaffe 1, J.E. Wil l iams 2, S. Chomtho 9, M.S. Fewtrell  2 
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Patients with cystic fibrosis (CF) are at r isk of impaired bone mineralisation. 
Suboptimal vitamin K status might be a contributing factor. A im:  To measure and 
identify factors associated with bone mineralisation and turnover ha CF children. 
Metku~ds: Dual  X ray absorptiometry was performed in 29 CF children to assess 
bone mineral  content (BMC). Lung function was assessed using forced expiratory 
volume (FEVI) and Chrispin Norman chest radiograph scoring system (CNS). 
Blood specimens were analyzed for 25 OH vitamin D, PTH, plasma total 
osteocalcin and intact P1NP. % uncarboxylated ostec~alcin (ucOC) was determined. 
Deoxypyridinolinelcreatinine (DPD/creat) ratio in urine samples was assessed. 
Results: Mean height and lumbar spine (LS) BMC, but not size adjusted LS bone 
mass (LS BM), were low in pre pubertal CF subjects compared to healthy children. 
P1NP was low in CF subjects compared to Swiss adolescents. DPD/creat ratio was 
h igh compared to healthy Br i t ish children. 25 OH v i tamin D and PTH 
concentrations were normal. % ucOC was similar to that previously reported ha 
vitamin K deficient CF patients. Alter adjusting for age, sex, pubertal status, bone 
and body size, %ucOC was a significant predictor of LS BMC (0.4% decrease ha 
BMD per 1% increase in ucOC), but not bone area. Other bone tunaover markers 
did not predict BMD. FEV v CNS and genotype were no significant predictors of 
BM or bone turnover. Conclusion: 8 12 year old CF children had normal size 
adjusted BM. However, comparison with l imited available reference data suggests, 
that bone formation may be reduced and bone resorption increased. % ucOC, a 
l ikely indicator of vitamin K status, is inversely related to BM. 
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Microvascular complications have been repotted ha patients with CFRD, the 
duration of diabetes and level of glycaemic ontrol being the main r isk factors, ha 
our unit a dedicated specialist nurse supervises an active CFRD screening mad 
treatment programme. To assess the prevalence of diabetic nephropathy and 
potential interaction with aminoglycoside (AG) nephrotoxicity, we  studied renal 
function prospectively ha 15 patients with CFRD [mean duration of insulin therapy 
3 yrs, mean HbA lc  6.3] matched to 30 non diabetic CF controls [age: 23 vs 22.4 yr; 
BMI:  20.9 vs 21.2 kg/m2; FEV1% predicted: 63 vs 65; all cbr onically infected with 
Pseudomonas aemginosa; similar previous treatment with AG and / or colistin 
(mean 1.5 v 1.7 courses/yr)]. 24 hour urine was collected in the outpatient clinic 
and before and after 14 days inpatient iv t obr amycin and colistin. 
In clinically stable patients attending the outpatient clinic baseline creatinine 
clearance (CCL) did not differ between the 2 groups [mean 81 v 77 ml/min; % 
<80 ml/min: 4/15 vs 11/30]. None had pathological proteinuria, but persistent 
microalbuminuria w s present in 3 and 1 respectively. 
Treatment related changes in CCL, total proteinuria,  ur inary N 
acetylglucoseminidase (a tubular cell enzyme), and B2 microglobulin (a marker of 
tubular injury) were similar in both groups [16 v 20% from baseline, 0.30 v 
0.27 rag/day,0.47 v 0.44 IU/mmol, 0.78 v 0.81 pghnmol].  
Therefore, CFRD did not impact on renal function in our patient series. The short 
duration of CFRD could partly explain this; however, our policy of effective 
screening, early treatment and close monitoring of CFRD also appears to protect 
against diabetic nephr apathy. Furthermore, AG induced changes in tubular function 
did not interact with CFRD, nor did micr oalbuminuria cottelate with CCL. 
